Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling

Brain Behav Immun. 2022 May:102:11-22. doi: 10.1016/j.bbi.2022.02.007. Epub 2022 Feb 7.

Abstract

Gut microbiome disturbances have been widely implicated in major depressive disorder (MDD), although the identity of causal microbial species and the underlying mechanisms are yet to be fully elucidated. Here we show that Bacteroides species enriched in the gut microbiome from MDD patients differentially impact the susceptibility to depressive behaviors. Transplantation of fecal microbiome from MDD patients into antibiotic-treated mice induced anxiety and despair-like behavior and impaired hippocampal neurogenesis. Colonization of Bacteroides fragilis, Bacteroides uniformis, and, to a lesser extent, Bacteroides caccae, but not Bacteroides ovatus, recapitulated the negative effects of MDD microbiome on behavior and neurogenesis. The varying impacts of Bacteroides species were partially explained by differential alternations of tryptophan pathway metabolites and neurotransmitters along the gut-brain axis. Notably, an intensified depletion of cerebral serotonin concurred with the enhanced susceptibility to depression. Together, these findings identify select Bacteroidetes species that contribute to depression susceptibility in mice by metabolic regulation along the gut-brain axis.

Keywords: Bacteroides; Fecal microbiota transplantation; Gut microbiome; Gut-brain axis; Major depressive disorder; Metabolic regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacteroides
  • Brain / metabolism
  • Depression / metabolism
  • Depressive Disorder, Major* / metabolism
  • Gastrointestinal Microbiome* / physiology
  • Humans
  • Mice